GE HealthCare and DeepHealth Collaborate to Advance AI-Powered Breast Cancer Screening

GE HealthCare and DeepHealth Forge Strategic Partnership

GE HealthCare Technologies Inc. (GEHC) and DeepHealth, a subsidiary of RadNet, Inc. (RDNT), have announced a strategic collaboration aimed at advancing artificial intelligence (AI) in medical imaging, with a primary focus on breast cancer screening 1

1

2

2

. This partnership seeks to develop and commercialize SmartTechnology solutions that leverage AI to address key challenges in the imaging value chain.

Enhancing Breast Cancer Screening with AI

The collaboration's initial focus is on integrating DeepHealth's AI-based SmartMammo workflow and clinical solution with GE HealthCare's Senographe Pristina mammography system 2

2

. This integration aims to bring AI-powered clinical imaging support to breast cancer screening, potentially improving detection and diagnosis during critical early stages of treatment.

Key features of the integrated solution include:

1. Cloud-native smart enterprise image viewer with PACS functionality
2. Integration with radiologist worklist and reporting tools
3. AI detection tools offering automatic lesion localization and suspicion grading

Smart Alerts for Rapid Response

The partnership also plans to incorporate Smart Alerts, a DeepHealth workflow solution integrated with Senographe Pristina 1

1

. This feature utilizes rapid AI processing to identify potentially suspicious lesions within minutes, enabling:

• Same-day diagnostic exams
• Improved follow-up compliance
• Reduced anxiety for women with potentially concerning findings

Expanding AI Applications in Healthcare

Beyond breast cancer screening, GE HealthCare and DeepHealth plan to explore further collaborations on SmartTechnology solutions in other modalities and clinical domains 1

1

2

2

. This expansion aims to:

1. Increase efficiency in imaging interpretation and reporting
2. Enable better collaboration across care teams
3. Improve clinical interpretation of images
4. Enhance operational efficiency and productivity

Industry Impact and Distribution

As part of the agreement, GE HealthCare will distribute SmartMammo and other DeepHealth solutions to imaging providers across the United States 1

1

. This distribution will be integrated into GE HealthCare's comprehensive portfolio of imaging technologies, potentially broadening the impact of AI-powered workflows in healthcare settings.

Executive Perspectives

Roland Rott, President & Chief Executive Officer of Imaging for GE HealthCare, emphasized the promise of AI in breast cancer screening, stating, "AI continues to show great promise in breast cancer screening from early detection and risk prediction, to reduced callbacks and more efficient workflows for breast imaging providers." 1

1

Kees Wesdorp, President and CEO of RadNet's Digital Health division, expressed enthusiasm about the collaboration, highlighting the potential to "revolutionize large-scale diagnostic and screening programs, streamline radiology workflows, and improve patient outcomes." 2

2

Market Response

The announcement has generated interest in the financial markets, with GE HealthCare shares showing a slight increase in premarket trading 1

1

. Investors looking to gain exposure to this development can consider ETFs such as Spinnaker ETF Series Langar Global HealthTech ETF (LGHT) and Invesco S&P Spin-Off ETF (CSD).

As the global cancer burden continues to rise, this collaboration between GE HealthCare and DeepHealth represents a significant step towards leveraging AI to address critical healthcare challenges, potentially transforming breast cancer screening and paving the way for broader applications of AI in medical imaging.